Study 4

TITLE

[Anti-androgen therapy in the female]. Antiandrogentherapie bei der Frau. 31 REFS

AUTHOR
Schindler AE

ORGANISATION
Zentrum fur Frauenheilkunde, Universitatsklinikum Essen.

SOURCE
Geburtshilfe Frauenheilkd 1990 Oct; 50 (10): 749-53

LANGUAGE OF PUBLICATION
German (1350-)

ABSTRACT
Besides the various androgenic activities actions in women, signs of androgenisation such as acne, seborrhoe, hirsutism and alopecia, play an important clinical role and require a proper diagnostic evaluation and individualised medical treatment. After development and thorough clinical evaluation of antiandrogen, a variety of therapeutic possibilities have become available. The main antiandrogens are: Cyproterone acetate, chlormadinone acetate and spironolactone. They are used in mono- or combination-therapy regimens. Means of application (oral, parenteral), dosages used and different forms of combination therapies are presented under practical aspects. The effects of such treatment modalities are outlined. (AUTHOR)

MJTR: Androgen Antagonists TU. Androgens BL.

MNTR: Chlormadinone Acetate TU. Cyproterone AA. Cyproterone TU. English Abstract. Female. Human. Spironolactone TU. JOURNAL ARTICLE. REVIEW. REVIEW, TUTORIAL

RNUM: 0 (Androgen Antagonists); 0 (Androgens); 2098-66-0 (Cyproterone); 302-22-7 (Chlormadinone Acetate); 427-51-0 (Cyproterone Acetate); 52-01-7 (Spironolactone)

GEOT: GERMANY

IDEN: ISSN: 0016-5751. JOURNAL-CODE: FK5. ENTRY-DATE: 910322. JOURNAL-SUBSET: M. IM-DATE: 9105.

ACCE: 91138933